Blood tests to find genetic changes in brain AVM
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial uses a blood test to look for genetic mutations in brain arteriovenous malformations (bAVMs). It may help doctors understand these lesions better and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are being treated for a brain AVM at Pitié-Salpêtrière Hospital
- Your treatment plan includes embolization followed by surgery decided by a team of specialists
- You are willing to have embolization, with surgery possibly within 24-48 hours if needed
- You agree to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test (called a 'liquid biopsy') can find specific genetic changes in people with cerebral arteriovenous malformations. It aims to help doctors better understand and possibly manage this condition.
This study looks at how brain arteriovenous malformations (abnormal connections between arteries and veins in the brain) behave over time, and how different treatment choices affect outcomes. It may help researchers better predict prognosis and guide future care.
This study looks at genetic (inherited DNA) factors in people with certain abnormal blood vessel connections in the brain or spinal cord. It may help researchers understand why these malformations happen and how they might behave over time.
This study checks people long-term after a procedure called embolization, which blocks abnormal blood vessel connections in the brain (arteriovenous malformations). It may help doctors learn how well the treatment lasts over time and what outcomes to expect.
This trial tests a medication called bevacizumab (given as an IV infusion) to see if it can improve symptoms in people with brain arteriovenous malformations (AVMs) that cannot be treated with standard therapies. It is for those whose AVMs cause significant disability.
This trial tests a drug injected directly into the brain's abnormal blood vessels to see if it can help people who can't have surgery or other standard treatments. It may reduce symptoms and prevent future bleeding.
Hear when a new Brain Arterial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.